Collegium Pharmaceutical
COLL
#6457
Rank
โ‚น90.99 B
Marketcap
โ‚น2,805
Share price
1.24%
Change (1 day)
-2.60%
Change (1 year)

Revenue for Collegium Pharmaceutical (COLL)

Revenue in 2026 (TTM): โ‚น71.24 Billion

According to Collegium Pharmaceutical 's latest financial reports the company's current revenue (TTM ) is โ‚น75.80 Billion. In 2025 the company made a revenue of โ‚น70.07 Billion an increase over the revenue in the year 2024 that were of โ‚น54.16 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Collegium Pharmaceutical from 2014 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น71.24 B1.68%
2025 โ‚น70.07 B29.35%
2024 โ‚น54.16 B14.81%
2023 โ‚น47.18 B22.9%
2022 โ‚น38.39 B86.29%
2021 โ‚น20.60 B-9.11%
2020 โ‚น22.67 B7.16%
2019 โ‚น21.15 B7.91%
2018 โ‚น19.60 B978.37%
2017 โ‚น1.81 B1463.78%
2016 โ‚น0.11 B
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
United Therapeutics
UTHR
โ‚น301.75 B 298.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
โ‚น2.05 B-97.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
โ‚น346.94 B 357.65%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
KemPharm
KMPH
โ‚น0.99 B-98.69%๐Ÿ‡บ๐Ÿ‡ธ USA